StockMacro
Company, fund or insider

Help

Menu

Microbot Medical

$0.68 -62% in 6 monthsMarket cap $45.7M

MBOT on XNAS, Health Care, Microbot Medical, Inc., job postings

Measures activity, not value. Not investment advice.

Shares fell 61% in a year while cash of $61.8M is above the $49.9M market value.

  • BadFree cash outflow of $19.6M over the last 12 months
  • BadShort interest at 9.4% of shares, up 5.6% on the prior report

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.

Industry
Surgical & medical instruments & apparatus (Health Care)
Employees
22
Website
microbotmedical.com
Listed
Nasdaq, US
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $72K, net loss $5.8M.
Quarter to 31 Dec 2021: revenue –, net income -$3.9MQuarter to 31 Mar 2022: revenue –, net income -$3.2MQuarter to 30 Jun 2022: revenue –, net income -$3.5MQuarter to 30 Sep 2022: revenue –, net income -$3.5MQuarter to 31 Dec 2022: revenue –, net income -$3.0MQuarter to 31 Mar 2023: revenue –, net income -$2.9MQuarter to 30 Jun 2023: revenue –, net income -$2.3MQuarter to 30 Sep 2023: revenue –, net income -$2.4MQuarter to 31 Dec 2023: revenue –, net income -$3.2MQuarter to 31 Mar 2024: revenue –, net income -$2.4MQuarter to 30 Jun 2024: revenue –, net income -$2.5MQuarter to 30 Sep 2024: revenue –, net income -$3.2MQuarter to 31 Dec 2024: revenue –, net income -$3.4MQuarter to 31 Mar 2025: revenue –, net income -$2.6MQuarter to 30 Jun 2025: revenue –, net income -$3.5MQuarter to 30 Sep 2025: revenue –, net income -$3.6MQuarter to 31 Dec 2025: revenue –, net income -$3.5MQuarter to 31 Mar 2026: revenue $105K, net income -$3.7MQuarter to 31 Mar 2026: revenue $105K, net income -$3.7MQuarter to 30 Jun 2026: revenue $241K, net income -$5.6MQuarter to 30 Jun 2026: revenue $241K, net income -$5.6MQuarter to 30 Sep 2026: revenue $72K, net income -$5.8MQuarter to 30 Sep 2026: revenue $72K, net income -$5.8M
31 Dec 2021RevenueNet incomeNet losstallest bar $5.8M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$72K-$5.8M
30 Jun 2026$241K-$5.6M
31 Mar 2026$105K-$3.7M
31 Dec 2025–-$3.5M
30 Sep 2025–-$3.6M
30 Jun 2025–-$3.5M
31 Mar 2025–-$2.6M
31 Dec 2024–-$3.4M
30 Sep 2024–-$3.2M
30 Jun 2024–-$2.5M
31 Mar 2024–-$2.4M
31 Dec 2023–-$3.2M
30 Sep 2023–-$2.4M
30 Jun 2023–-$2.3M
31 Mar 2023–-$2.9M
31 Dec 2022–-$3.0M
30 Sep 2022–-$3.5M
30 Jun 2022–-$3.5M
31 Mar 2022–-$3.2M
31 Dec 2021–-$3.9M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. – –
Revenue growthRevenue of the last 12 months compared with the 12 months before. – +13%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$18.6M -$13.1M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$0.26 -$0.45
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 60.5%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – – -8.3%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. – – -10.1%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -26.3% -26.3%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. -$19.6M -$11.0M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $61.8M $80.2M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $0 $0
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$61.8M (net cash) -$80.2M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.0 0.31
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $0.94
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 28.0
P/SPrice to sales: market cap divided by revenue of the last 12 months. – 2.3
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 2.5
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 0.72 2.8

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Microbot MedicalMBOT (this company) $45.7Mloss–––
RenovoRxRNXT $45.5Mloss16.4–-469%
DaxorDXR $43.5M––––
LensarLNSR $54.8M–0.91+1.6%56.1%
Sensus HealthcareSRTS $37.2Mloss2.2-53%-96.5%
Spectral AIMDAI $33.5Mloss2.3-38%-70.5%

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+1.4%

72 13F filers vs 71

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

17%

11.5M shares held by 13F filers (30 Sep 2026) of 67.2M outstanding (12 Nov 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

9.4%

6.3M shares sold short (30 Oct 2026) of 67.2M outstanding (12 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

7.8

6.3M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+5.6%

6.0M shares sold short in the report before, 6.3M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

51%

51% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 46%

News Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

16

16 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

16×

16 articles in the last 7 days; its usual week has 1.

Price $0.68 on 20 Nov 2026, -61% over 12 months (12-month range $0.64 to $2.85)

  • Sharp change
  • 8-K and other filings
Revenue per quarter. Revenue $72K in the latest quarter.
Capital spending per quarter. Capital spending $115K in the latest quarter, +785% on a year earlier.
Institutional holders (13F filers). 72 13F filers reported holding it in the latest 13F quarter, +11% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: insider net buying (open market), h-1b/e-3 applications certified, federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
7 Aug 20268-K and other filingsDirector or officer change
7 Aug 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
24 Feb 20268-K and other filingsDirector or officer change
24 Feb 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
18 Nov 2025Sharp changeMany funds opening a new position: many funds opening a new position, 26 vs usual 7 (2025-09-30); 13.0x the same period a year earlier
29 Sep 20258-K and other filingsPrivate placement of securities (Form D)
19 Sep 20258-K and other filingsDirector or officer change
19 Sep 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
29 Jul 2025Sharp changeShort interest spike: short interest spike, 8.0M vs usual 1.4M (2025-07-15); 44.3x the same period a year earlier
1 Jul 2025Sharp changeShort interest spike: short interest spike, 8.1M vs usual 584K (2025-06-13); 21.5x the same period a year earlier
17 Jun 2025Sharp changeShort interest spike: short interest spike, 7.9M vs usual 579K (2025-05-30); 26.7x the same period a year earlier
3 Jun 2025Sharp changeShort interest spike: short interest spike, 6.8M vs usual 572K (2025-05-15); 22.2x the same period a year earlier
13 May 2025Sharp changeShort interest spike: short interest spike, 6.4M vs usual 478K (2025-04-30); 18.7x the same period a year earlier
29 Apr 2025Sharp changeShort interest spike: short interest spike, 5.5M vs usual 383K (2025-04-15); 21.6x the same period a year earlier
15 Apr 2025Sharp changeShort interest spike: short interest spike, 5.4M vs usual 359K (2025-03-31); 31.3x the same period a year earlier
1 Apr 2025Sharp changeShort interest spike: short interest spike, 5.1M vs usual 331K (2025-03-14); 57.2x the same period a year earlier
18 Mar 2025Sharp changeShort interest spike: short interest spike, 5.0M vs usual 312K (2025-02-28); 224.5x the same period a year earlier
4 Mar 2025Sharp changeShort interest spike: short interest spike, 4.8M vs usual 304K (2025-02-14); 151.7x the same period a year earlier
18 Feb 2025Sharp changeShort interest spike: short interest spike, 4.2M vs usual 299K (2025-01-31); 54.4x the same period a year earlier
18 Feb 20258-K and other filingsPrivate placement of securities (Form D)
10 Feb 20258-K and other filingsRegistered new securities for sale (S-1)
7 Feb 20258-K and other filingsDirector or officer change
4 Feb 20258-K and other filingsRegistered new securities for sale (S-1)
28 Jan 2025Sharp changeShort interest spike: short interest spike, 1.8M vs usual 282K (2025-01-15); 20.3x the same period a year earlier
24 Jan 20258-K and other filingsDirector or officer change
22 Jan 20258-K and other filingsPrivate placement of securities (Form D)
22 Jan 20258-K and other filingsPrivate placement of securities (Form D)
14 Jan 2025Sharp changeShort interest spike: short interest spike, 1.0M vs usual 263K (2024-12-31); 37.1x the same period a year earlier
19 Dec 20248-K and other filingsDirector or officer change
19 Dec 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
11 Oct 20248-K and other filingsDelisting notice or listing transfer
20 Jun 20248-K and other filingsRegistered new securities for sale (S-1)
20 Jun 20248-K and other filingsPrivate placement of securities (Form D)
11 Jun 20248-K and other filingsRegistered new securities for sale (S-1)
1 Apr 20248-K and other filingsRegistered new securities for sale (S-1)
26 Feb 20248-K and other filingsDirector or officer change
20 Feb 20248-K and other filingsRegistered new securities for sale (S-1)
22 Jan 20248-K and other filingsRegistered new securities for sale (S-1)
12 Jan 20248-K and other filingsDirector or officer change
12 Jan 20248-K and other filingsRegistered new securities for sale (S-1)
21 Nov 20238-K and other filingsDirector or officer change
14 Nov 20238-K and other filingsDirector or officer change
5 Sep 20238-K and other filingsDirector or officer change
5 Sep 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
14 Jul 20238-K and other filingsRegistered new securities for sale (S-1)
11 Jul 20238-K and other filingsRegistered new securities for sale (S-1)
13 Jun 2023Sharp changeShort interest spike: short interest spike, 630K vs usual 95K (2023-05-31); 5.3x the same period a year earlier
22 May 20238-K and other filingsDirector or officer change
22 May 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
16 May 20238-K and other filingsReport will be filed late
23 Jan 20238-K and other filingsDirector or officer change
23 Jan 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
6 Apr 20228-K and other filingsDirector or officer change
1 Feb 20228-K and other filingsDirector or officer change
1 Feb 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Revenue per quarter
Quarter ended 31 Mar 2026: $105K; public on 14 May 2026
Quarter ended 30 Jun 2026: $241K; public on 12 Aug 2026
Quarter ended 30 Sep 2026: $72K; public on 14 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $44K, +450% on a year earlier; public on 1 Apr 2022
Quarter ended 31 Mar 2022: $16K, +220% on a year earlier; public on 17 May 2022
Quarter ended 30 Sep 2022: $5K, -64% on a year earlier; public on 15 Nov 2022
Quarter ended 31 Dec 2022: $1K, -98% on a year earlier; public on 1 Apr 2023
Quarter ended 30 Sep 2023: $28K, +460% on a year earlier; public on 15 Nov 2023
Quarter ended 31 Mar 2024: $14K; public on 16 May 2024
Quarter ended 30 Jun 2024: $4K; public on 15 Aug 2024
Quarter ended 31 Dec 2024: $7K; public on 26 Mar 2025
Quarter ended 31 Mar 2025: $13K, -7.1% on a year earlier; public on 15 May 2025
Quarter ended 30 Jun 2025: $9K, +125% on a year earlier; public on 13 Aug 2025
Quarter ended 30 Sep 2025: $13K; public on 13 Nov 2025
Quarter ended 31 Dec 2025: $25K, +257% on a year earlier; public on 27 Mar 2026
Quarter ended 31 Mar 2026: $108K, +731% on a year earlier; public on 14 May 2026
Quarter ended 30 Jun 2026: $142K, +1478% on a year earlier; public on 12 Aug 2026
Quarter ended 30 Sep 2026: $115K, +785% on a year earlier; public on 14 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 21; public on 14 Feb 2022
31 Mar 2022 report: 27; public on 16 May 2022
30 Jun 2022 report: 25; public on 15 Aug 2022
30 Sep 2022 report: 22; public on 14 Nov 2022
31 Dec 2022 report: 23; public on 14 Feb 2023
31 Mar 2023 report: 27; public on 15 May 2023
30 Jun 2023 report: 26; public on 14 Aug 2023
30 Sep 2023 report: 27; public on 14 Nov 2023
31 Dec 2023 report: 31; public on 14 Feb 2024
31 Mar 2024 report: 31; public on 15 May 2024
30 Jun 2024 report: 30; public on 14 Aug 2024
30 Sep 2024 report: 22; public on 14 Nov 2024
31 Dec 2024 report: 36; public on 14 Feb 2025
31 Mar 2025 report: 41; public on 15 May 2025
30 Jun 2025 report: 47; public on 14 Aug 2025
30 Sep 2025 report: 65; public on 14 Nov 2025
31 Dec 2025 report: 67; public on 17 Feb 2026
31 Mar 2026 report: 77; public on 15 May 2026
30 Jun 2026 report: 71; public on 14 Aug 2026
30 Sep 2026 report: 72; public on 16 Nov 2026

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is gross profit, quarter at -$1.0M (30 Sep 2026), 616% below its normal quarter of $198K; higher than 5% of its own history.
  • Revenue per quarter: Revenue $72K in the latest quarter.
  • Capital spending per quarter: Capital spending $115K in the latest quarter, +785% on a year earlier.
  • Institutional holders (13F filers): 72 13F filers reported holding it in the latest 13F quarter, +11% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 35 insider trades

No trades in the last 90 days; the latest was filed 21 Oct 2020. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
21 Oct 2020Yoseph BornsteinDirectorSell4,881$7.94$39KForm 4
13 Oct 2020Yoseph BornsteinDirectorSell20,000$7.84$157KForm 4
6 Oct 2020Yoseph BornsteinDirectorSell20,000$7.74$155KForm 4
19 Aug 2020Yoseph BornsteinDirectorSell15,119$10.19$154KForm 4
26 Dec 2019Harel GadotChairman, President and CEOSell40,000$10.00$400KForm 4
10 Jan 2018Yoseph BornsteinDirector, 10% ownerSell35,000$1.06$37KForm 4
4 Jan 2018Yoseph BornsteinDirector, 10% ownerSell2,868$1.01$3KForm 4
3 Jan 2018Yoseph BornsteinDirector, 10% ownerSell42,132$1.01$43KForm 4

72 institutions reported shares at the end of Q3 2026, 17% of the shares outstanding; 11 opened a position, 11 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Vanguard Capital Management LLC2.9M4.31%$3.5M-13K-0.5%
Mitsubishi UFJ Asset Management Co., Ltd.1.3M1.98%$1.6M+64K+5.0%
BlackRock, Inc.892K1.33%$1.1M-11K-1.2%
UBS Group AG843K1.26%$1.0M+36K+4.5%
Geode Capital Management, LLC780K1.16%$937K-56K-6.7%
DNB Asset Management As677K1.01%$813KNo change
Stifel Financial Corp559K0.83%$671K-31K-5.3%
Susquehanna International Group, LLP539K0.80%$647K+13K+2.5%
Vanguard Fiduciary Trust Co431K0.64%$517KNo change
Marshall Wace, LLP417K0.62%$500K-125K-23%

In 12 months: 2 major agreements, 2 director or officer changes. Results releases and routine reports are left out.

FiledWhat happenedSource
7 Aug 2026Director or officer change; Signed a major agreement8-K
24 Feb 2026Director or officer change; Signed a major agreement8-K
7 Oct 2025Signed a major agreementSame filing: sold shares privately8-K
3 Oct 2025Signed a major agreementSame filing: sold shares privately8-K
29 Sep 2025Private placement of securities (Form D)$25.2M sold of $25.2M offeredD
19 Sep 2025Director or officer change8-K
16 Sep 2025Signed a major agreementSame filing: sold shares privately8-K
18 Feb 2025Private placement of securities (Form D)$13.0M sold of $13.0M offeredD

The 5 newest of 104 articles that name the company.

Timeline

Timeline

Changes and notable records, by the date each became public

  1. 7 Aug 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  2. 7 Aug 2026Filings record

    Director or officer change

  3. 24 Feb 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  4. 24 Feb 2026Filings record

    Director or officer change

  5. 14 Nov 2025Institutional holdings change

    saw 26 13F filers open a new position in the quarter ended 30 Sep 2025, 13× the same quarter last year.

    Same quarter last year: 2; its normal quarter is 7.

    See the evidence
    This period
    26 (the quarter ended 30 Sep 2025)
    Normal quarter (median of 8 earlier)
    7
    Typical spread (median absolute deviation)
    2
    How far from its usual level
    +6.3
    Same quarter last year
    2
    History used
    3,195 days
    2023-09-30: 52023-12-31: 92024-03-31: 52024-06-30: 52024-09-30: 22024-12-31: 92025-03-31: 102025-06-30: 132025-09-30: 26
    the quarter ended 30 Sep 20258 earlier quartersnormal: 7

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  6. 29 Sep 2025Filings record

    Private placement of securities (Form D)

  7. 19 Sep 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  8. 19 Sep 2025Filings record

    Director or officer change

  9. 25 Jul 2025Short interest and volume change

    had 8.0M shares sold short in the 15 Jul 2025 report, 44× the same report last year.

    Same report last year: 180K; its normal report is 1.4M.

    See the evidence
    This period
    8.0M (the 15 Jul 2025 report)
    Normal report (median of 24 earlier)
    1.4M
    Typical spread (median absolute deviation)
    1.2M
    How far from its usual level
    +3.6
    Same report last year
    180K
    History used
    2,755 days
    2024-07-15: 180K2024-07-31: 191K2024-08-15: 177K2024-08-30: 206K2024-09-13: 271K2024-09-30: 319K2024-10-15: 390K2024-10-31: 566K2024-11-15: 587K2024-11-29: 581K2024-12-13: 578K2024-12-31: 1.0M2025-01-15: 1.8M2025-01-31: 4.2M2025-02-14: 4.8M2025-02-28: 5.0M2025-03-14: 5.1M2025-03-31: 5.4M2025-04-15: 5.5M2025-04-30: 6.4M2025-05-15: 6.8M2025-05-30: 7.9M2025-06-13: 8.1M2025-06-30: 7.9M2025-07-15: 8.0M
    the 15 Jul 2025 report24 earlier reportsnormal: 1.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  10. 26 Jun 2025Short interest and volume change

    had 8.1M shares sold short in the 13 Jun 2025 report, 21× the same report last year.

    Same report last year: 375K; its normal report is 584K.

    See the evidence
    This period
    8.1M (the 13 Jun 2025 report)
    Normal report (median of 24 earlier)
    584K
    Typical spread (median absolute deviation)
    406K
    How far from its usual level
    +12.4
    Same report last year
    375K
    History used
    2,723 days
    2024-06-14: 375K2024-06-28: 304K2024-07-15: 180K2024-07-31: 191K2024-08-15: 177K2024-08-30: 206K2024-09-13: 271K2024-09-30: 319K2024-10-15: 390K2024-10-31: 566K2024-11-15: 587K2024-11-29: 581K2024-12-13: 578K2024-12-31: 1.0M2025-01-15: 1.8M2025-01-31: 4.2M2025-02-14: 4.8M2025-02-28: 5.0M2025-03-14: 5.1M2025-03-31: 5.4M2025-04-15: 5.5M2025-04-30: 6.4M2025-05-15: 6.8M2025-05-30: 7.9M2025-06-13: 8.1M
    the 13 Jun 2025 report24 earlier reportsnormal: 584K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  11. 11 Jun 2025Short interest and volume change

    had 7.9M shares sold short in the 30 May 2025 report, 27× the same report last year.

    Same report last year: 294K; its normal report is 579K.

    See the evidence
    This period
    7.9M (the 30 May 2025 report)
    Normal report (median of 24 earlier)
    579K
    Typical spread (median absolute deviation)
    394K
    How far from its usual level
    +12.5
    Same report last year
    294K
    History used
    2,709 days
    2024-05-31: 294K2024-06-14: 375K2024-06-28: 304K2024-07-15: 180K2024-07-31: 191K2024-08-15: 177K2024-08-30: 206K2024-09-13: 271K2024-09-30: 319K2024-10-15: 390K2024-10-31: 566K2024-11-15: 587K2024-11-29: 581K2024-12-13: 578K2024-12-31: 1.0M2025-01-15: 1.8M2025-01-31: 4.2M2025-02-14: 4.8M2025-02-28: 5.0M2025-03-14: 5.1M2025-03-31: 5.4M2025-04-15: 5.5M2025-04-30: 6.4M2025-05-15: 6.8M2025-05-30: 7.9M
    the 30 May 2025 report24 earlier reportsnormal: 579K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  12. 28 May 2025Short interest and volume change

    had 6.8M shares sold short in the 15 May 2025 report, 22× the same report last year.

    Same report last year: 305K; its normal report is 572K.

    See the evidence
    This period
    6.8M (the 15 May 2025 report)
    Normal report (median of 24 earlier)
    572K
    Typical spread (median absolute deviation)
    373K
    How far from its usual level
    +11.2
    Same report last year
    305K
    History used
    2,694 days
    2024-05-15: 305K2024-05-31: 294K2024-06-14: 375K2024-06-28: 304K2024-07-15: 180K2024-07-31: 191K2024-08-15: 177K2024-08-30: 206K2024-09-13: 271K2024-09-30: 319K2024-10-15: 390K2024-10-31: 566K2024-11-15: 587K2024-11-29: 581K2024-12-13: 578K2024-12-31: 1.0M2025-01-15: 1.8M2025-01-31: 4.2M2025-02-14: 4.8M2025-02-28: 5.0M2025-03-14: 5.1M2025-03-31: 5.4M2025-04-15: 5.5M2025-04-30: 6.4M2025-05-15: 6.8M
    the 15 May 2025 report24 earlier reportsnormal: 572K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  13. 10 May 2025Short interest and volume change

    had 6.4M shares sold short in the 30 Apr 2025 report, 19× the same report last year.

    Same report last year: 343K; its normal report is 478K.

    See the evidence
    This period
    6.4M (the 30 Apr 2025 report)
    Normal report (median of 24 earlier)
    478K
    Typical spread (median absolute deviation)
    239K
    How far from its usual level
    +16.7
    Same report last year
    343K
    History used
    2,679 days
    2024-04-30: 343K2024-05-15: 305K2024-05-31: 294K2024-06-14: 375K2024-06-28: 304K2024-07-15: 180K2024-07-31: 191K2024-08-15: 177K2024-08-30: 206K2024-09-13: 271K2024-09-30: 319K2024-10-15: 390K2024-10-31: 566K2024-11-15: 587K2024-11-29: 581K2024-12-13: 578K2024-12-31: 1.0M2025-01-15: 1.8M2025-01-31: 4.2M2025-02-14: 4.8M2025-02-28: 5.0M2025-03-14: 5.1M2025-03-31: 5.4M2025-04-15: 5.5M2025-04-30: 6.4M
    the 30 Apr 2025 report24 earlier reportsnormal: 478K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  14. 26 Apr 2025Short interest and volume change

    had 5.5M shares sold short in the 15 Apr 2025 report, 22× the same report last year.

    Same report last year: 255K; its normal report is 383K.

    See the evidence
    This period
    5.5M (the 15 Apr 2025 report)
    Normal report (median of 24 earlier)
    383K
    Typical spread (median absolute deviation)
    193K
    How far from its usual level
    +17.9
    Same report last year
    255K
    History used
    2,664 days
    2024-04-15: 255K2024-04-30: 343K2024-05-15: 305K2024-05-31: 294K2024-06-14: 375K2024-06-28: 304K2024-07-15: 180K2024-07-31: 191K2024-08-15: 177K2024-08-30: 206K2024-09-13: 271K2024-09-30: 319K2024-10-15: 390K2024-10-31: 566K2024-11-15: 587K2024-11-29: 581K2024-12-13: 578K2024-12-31: 1.0M2025-01-15: 1.8M2025-01-31: 4.2M2025-02-14: 4.8M2025-02-28: 5.0M2025-03-14: 5.1M2025-03-31: 5.4M2025-04-15: 5.5M
    the 15 Apr 2025 report24 earlier reportsnormal: 383K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  15. 10 Apr 2025Short interest and volume change

    had 5.4M shares sold short in the 31 Mar 2025 report, 31× the same report last year.

    Same report last year: 173K; its normal report is 359K.

    See the evidence
    This period
    5.4M (the 31 Mar 2025 report)
    Normal report (median of 24 earlier)
    359K
    Typical spread (median absolute deviation)
    181K
    How far from its usual level
    +18.9
    Same report last year
    173K
    History used
    2,649 days
    2024-03-28: 173K2024-04-15: 255K2024-04-30: 343K2024-05-15: 305K2024-05-31: 294K2024-06-14: 375K2024-06-28: 304K2024-07-15: 180K2024-07-31: 191K2024-08-15: 177K2024-08-30: 206K2024-09-13: 271K2024-09-30: 319K2024-10-15: 390K2024-10-31: 566K2024-11-15: 587K2024-11-29: 581K2024-12-13: 578K2024-12-31: 1.0M2025-01-15: 1.8M2025-01-31: 4.2M2025-02-14: 4.8M2025-02-28: 5.0M2025-03-14: 5.1M2025-03-31: 5.4M
    the 31 Mar 2025 report24 earlier reportsnormal: 359K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  16. 26 Mar 2025Short interest and volume change

    had 5.1M shares sold short in the 14 Mar 2025 report, 57× the same report last year.

    Same report last year: 90K; its normal report is 331K.

    See the evidence
    This period
    5.1M (the 14 Mar 2025 report)
    Normal report (median of 24 earlier)
    331K
    Typical spread (median absolute deviation)
    153K
    How far from its usual level
    +21.1
    Same report last year
    90K
    History used
    2,632 days
    2024-03-15: 90K2024-03-28: 173K2024-04-15: 255K2024-04-30: 343K2024-05-15: 305K2024-05-31: 294K2024-06-14: 375K2024-06-28: 304K2024-07-15: 180K2024-07-31: 191K2024-08-15: 177K2024-08-30: 206K2024-09-13: 271K2024-09-30: 319K2024-10-15: 390K2024-10-31: 566K2024-11-15: 587K2024-11-29: 581K2024-12-13: 578K2024-12-31: 1.0M2025-01-15: 1.8M2025-01-31: 4.2M2025-02-14: 4.8M2025-02-28: 5.0M2025-03-14: 5.1M
    the 14 Mar 2025 report24 earlier reportsnormal: 331K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  17. 12 Mar 2025Short interest and volume change

    had 5.0M shares sold short in the 28 Feb 2025 report, 224× the same report last year.

    Same report last year: 22K; its normal report is 312K.

    See the evidence
    This period
    5.0M (the 28 Feb 2025 report)
    Normal report (median of 24 earlier)
    312K
    Typical spread (median absolute deviation)
    134K
    How far from its usual level
    +23.7
    Same report last year
    22K
    History used
    2,618 days
    2024-02-29: 22K2024-03-15: 90K2024-03-28: 173K2024-04-15: 255K2024-04-30: 343K2024-05-15: 305K2024-05-31: 294K2024-06-14: 375K2024-06-28: 304K2024-07-15: 180K2024-07-31: 191K2024-08-15: 177K2024-08-30: 206K2024-09-13: 271K2024-09-30: 319K2024-10-15: 390K2024-10-31: 566K2024-11-15: 587K2024-11-29: 581K2024-12-13: 578K2024-12-31: 1.0M2025-01-15: 1.8M2025-01-31: 4.2M2025-02-14: 4.8M2025-02-28: 5.0M
    the 28 Feb 2025 report24 earlier reportsnormal: 312K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  18. 27 Feb 2025Short interest and volume change

    had 4.8M shares sold short in the 14 Feb 2025 report, 152× the same report last year.

    Same report last year: 31K; its normal report is 304K.

    See the evidence
    This period
    4.8M (the 14 Feb 2025 report)
    Normal report (median of 24 earlier)
    304K
    Typical spread (median absolute deviation)
    126K
    How far from its usual level
    +23.8
    Same report last year
    31K
    History used
    2,604 days
    2024-02-15: 31K2024-02-29: 22K2024-03-15: 90K2024-03-28: 173K2024-04-15: 255K2024-04-30: 343K2024-05-15: 305K2024-05-31: 294K2024-06-14: 375K2024-06-28: 304K2024-07-15: 180K2024-07-31: 191K2024-08-15: 177K2024-08-30: 206K2024-09-13: 271K2024-09-30: 319K2024-10-15: 390K2024-10-31: 566K2024-11-15: 587K2024-11-29: 581K2024-12-13: 578K2024-12-31: 1.0M2025-01-15: 1.8M2025-01-31: 4.2M2025-02-14: 4.8M
    the 14 Feb 2025 report24 earlier reportsnormal: 304K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  19. 18 Feb 2025Filings record

    Private placement of securities (Form D)

  20. 12 Feb 2025Short interest and volume change

    had 4.2M shares sold short in the 31 Jan 2025 report, 54× the same report last year.

    Same report last year: 77K; its normal report is 299K.

    See the evidence
    This period
    4.2M (the 31 Jan 2025 report)
    Normal report (median of 24 earlier)
    299K
    Typical spread (median absolute deviation)
    121K
    How far from its usual level
    +21.7
    Same report last year
    77K
    History used
    2,590 days
    2024-01-31: 77K2024-02-15: 31K2024-02-29: 22K2024-03-15: 90K2024-03-28: 173K2024-04-15: 255K2024-04-30: 343K2024-05-15: 305K2024-05-31: 294K2024-06-14: 375K2024-06-28: 304K2024-07-15: 180K2024-07-31: 191K2024-08-15: 177K2024-08-30: 206K2024-09-13: 271K2024-09-30: 319K2024-10-15: 390K2024-10-31: 566K2024-11-15: 587K2024-11-29: 581K2024-12-13: 578K2024-12-31: 1.0M2025-01-15: 1.8M2025-01-31: 4.2M
    the 31 Jan 2025 report24 earlier reportsnormal: 299K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  21. 10 Feb 2025Filings record

    Registered new securities for sale (S-1)

  22. 7 Feb 2025Filings record

    Director or officer change

  23. 4 Feb 2025Filings record

    Registered new securities for sale (S-1)

  24. 28 Jan 2025Short interest and volume change

    had 1.8M shares sold short in the 15 Jan 2025 report, 20× the same report last year.

    Same report last year: 89K; its normal report is 282K.

    See the evidence
    This period
    1.8M (the 15 Jan 2025 report)
    Normal report (median of 24 earlier)
    282K
    Typical spread (median absolute deviation)
    107K
    How far from its usual level
    +9.6
    Same report last year
    89K
    History used
    2,574 days
    2024-01-12: 89K2024-01-31: 77K2024-02-15: 31K2024-02-29: 22K2024-03-15: 90K2024-03-28: 173K2024-04-15: 255K2024-04-30: 343K2024-05-15: 305K2024-05-31: 294K2024-06-14: 375K2024-06-28: 304K2024-07-15: 180K2024-07-31: 191K2024-08-15: 177K2024-08-30: 206K2024-09-13: 271K2024-09-30: 319K2024-10-15: 390K2024-10-31: 566K2024-11-15: 587K2024-11-29: 581K2024-12-13: 578K2024-12-31: 1.0M2025-01-15: 1.8M
    the 15 Jan 2025 report24 earlier reportsnormal: 282K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  25. 24 Jan 2025Filings record

    Director or officer change

  26. 22 Jan 2025Filings record

    Private placement of securities (Form D)

  27. 22 Jan 2025Filings record

    Private placement of securities (Form D)

  28. 14 Jan 2025Short interest and volume change

    had 1.0M shares sold short in the 31 Dec 2024 report, 37× the same report last year.

    Same report last year: 28K; its normal report is 263K.

    See the evidence
    This period
    1.0M (the 31 Dec 2024 report)
    Normal report (median of 24 earlier)
    263K
    Typical spread (median absolute deviation)
    101K
    How far from its usual level
    +5.2
    Same report last year
    28K
    History used
    2,559 days
    2023-12-29: 28K2024-01-12: 89K2024-01-31: 77K2024-02-15: 31K2024-02-29: 22K2024-03-15: 90K2024-03-28: 173K2024-04-15: 255K2024-04-30: 343K2024-05-15: 305K2024-05-31: 294K2024-06-14: 375K2024-06-28: 304K2024-07-15: 180K2024-07-31: 191K2024-08-15: 177K2024-08-30: 206K2024-09-13: 271K2024-09-30: 319K2024-10-15: 390K2024-10-31: 566K2024-11-15: 587K2024-11-29: 581K2024-12-13: 578K2024-12-31: 1.0M
    the 31 Dec 2024 report24 earlier reportsnormal: 263K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  29. 19 Dec 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  30. 19 Dec 2024Filings record

    Director or officer change

  31. 11 Oct 2024Filings record

    Delisting notice or listing transfer

  32. 20 Jun 2024Filings record

    Registered new securities for sale (S-1)

  33. 20 Jun 2024Filings record

    Private placement of securities (Form D)

  34. 11 Jun 2024Filings record

    Registered new securities for sale (S-1)

  35. 1 Apr 2024Filings record

    Registered new securities for sale (S-1)

  36. 26 Feb 2024Filings record

    Director or officer change

  37. 20 Feb 2024Filings record

    Registered new securities for sale (S-1)

  38. 22 Jan 2024Filings record

    Registered new securities for sale (S-1)

  39. 12 Jan 2024Filings record

    Director or officer change

  40. 12 Jan 2024Filings record

    Registered new securities for sale (S-1)

Showing the newest 40 of 103 entries; narrow the window or the kind of data to see older ones.

Not listed: 229 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0000883975
Ticker
MBOT
Domain
microbotmedical.com
Hq location
MA|HINGHAM|02043 (1 unverified)
Name
CYTOTHERAPEUTICS INC/DE, Microbot Medical, Inc., STEMCELLS INC
  • SEC Form 13F institutional holdings360 data points31 Dec 2016 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)267 records12 Jan 2016 to 13 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)952 data points31 Dec 2008 to 12 Nov 2026
  • SEC Form 4 insider transactions35 records, 108 data points18 Apr 2016 to 21 Oct 2020
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026